Skip to content
Agentic OS
Menu

Intelligence / B2B SaaS / Acquisitions / Barinthus Biotherapeutics plc.

M&Awas acquired (SEC 8-K)9 Sept 2026

Barinthus Biotherapeutics plc.

9 Sept 2026: Was acquired (SEC 8-K) · Pharma and biotech. Recorded in the SEC EDGAR full-text search.

View the source record

Filed
9 Sept 2026
Ticker
BRNS
Role
Was acquired
Sector
Pharma and biotech
Sic
2834
Items
1.02, 2.01, 3.01, 3.03, 5.01, 9.01
Summary
This Current Report on Form 8-K is being filed in connection with the completion of the previously announced Transaction (as described below).
Location
Germantown, MD
State
Maryland
Country
United States
SEC CIK
1828185
Reference
0001104659-26-106183
What this signal means

Integration means consolidating tools and vendors: the buyer re-platforms the target, and an acquired company's stack is reviewed by its new owner.

  1. Completed an acquisition leads with 189 of 292, then Sold assets or a business (82).
  2. 103 added in the 30 days to 19 Nov 2026.
Reach them with AOS

Find the decision makers at Barinthus Biotherapeutics plc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this m&a signal, for your approval.

Start free

More in Was acquired

Acquisitions

See all

Source: SEC EDGAR full-text search, data to 19 Nov 2026. Every Form 8-K reporting Item 2.01 (completion of an acquisition or disposition of assets) filed with the SEC in the last 90 days. The role (buyer, company acquired, seller) is read from the filing's own wording, which is quoted on each row. AOS shows what the public record says; it does not verify or endorse the company.